Abbott Rapid Diagnostics A/S: Financial statements 2017
CVR: 24204650
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 18,158,716 and a net result of DKK 99,340 compared with DKK -329,692 the year before. That is a decrease of 2.9% compared with the year before. Equity in the 2017 report amounted to DKK 23,608,104. The solvency ratio was 61.9%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 18,158,716
- Profit/Loss
- DKK 99,340
- Equity
- DKK 23,608,104
- Total Assets
- DKK 38,144,466
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 18.2 mio. | 99 t. | 23.6 mio. | 23 |
| 2016 | - | 18.7 mio. | -330 t. | 23.5 mio. | 21 |
| 2015 | - | 23.4 mio. | 4.1 mio. | 23.8 mio. | 22 |
| 2014 | - | 20 mio. | -2.8 mio. | 19.8 mio. | 27 |
| 2013 | - | 19.4 mio. | -1.8 mio. | -3.6 mio. | 26 |
Official annual report
Keep an eye on Abbott Rapid Diagnostics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 20, 2017, Brian B. Yoor has joined the board of directors of Abbott Rapid Diagnostics A/S.
As of October 20, 2017, Kjersti Grimsrud has left the board of directors of Abbott Rapid Diagnostics A/S.
Abbott Rapid Diagnostics A/S has published its annual report for 2016. Gross profit came to DKK 18,701,907, and the net result was DKK -329,692.
As of March 1, 2017, Christopher Gustaf Aulin is registered as adm. dir. of Abbott Rapid Diagnostics A/S.
As of February 28, 2017, Andreas Lennart Gottlieb Juhlin has stepped down as director of Abbott Rapid Diagnostics A/S.
About Abbott Rapid Diagnostics A/S
Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.